A Proposition of an Auxiliary Treatment for Diabetes Mellitus, Type I
Medical Case Reports · 2017
DOI: 10.21767/2471-8041.100045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Case Reports, 2017. Verfasst von Kimihiko Okazaki.
Themen: Diabetes mellitus
Abstract (Originalsprache)
It is well known that diabetes mellitus, Type-I is an autoimmune disease. As a matter of course, all of patients of this disease should have anti-pancreatic B cell antibodies on the surface of cytolytic T lymphocytes. Few, if any, contemporary physicians seem to take this fact into consideration presumably because most, if not all, of them take it for granted that most, if not all, antibody molecules rigidly adhere to their receptors on cell-surfaces.
Zitieren
APA
Okazaki, K. (2017). A Proposition of an Auxiliary Treatment for Diabetes Mellitus, Type I. Medical Case Reports. https://doi.org/10.21767/2471-8041.100045
Vancouver
Okazaki K. A Proposition of an Auxiliary Treatment for Diabetes Mellitus, Type I. Medical Case Reports. 2017. doi:10.21767/2471-8041.100045
BibTeX
@article{Okazaki2017,
author = {Okazaki, Kimihiko},
title = {A Proposition of an Auxiliary Treatment for Diabetes Mellitus, Type I},
journal = {Medical Case Reports},
year = {2017},
doi = {10.21767/2471-8041.100045}
}
EUVIMED